Interview

A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research

Re-engineering pharmaceutical research, a scientist’s opinion Interview with Aroon Hingorani, Professor of Genetic Epidemiology at University College London. Could you speculate what you think are the biggest causes of drug failure? It is well recognised that the number one cause for drug failure is a lack of efficacy of the drug in the intended indication, ...

A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research

Re-engineering pharmaceutical research, a scientist’s opinion Interview with Dr Denis Lacombe, Director General of the European Organisation for Research and Treatment of Cancer (EORTC). Can you tell me a bit about the European Organisation for Research and Treatment of Cancer (EORTC)? We are a non-governmental, not-for-profit organisation established for 60 years, focusing on survival and ...

A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research

Re-engineering pharmaceutical research, a scientist’s opinion Interview with Dr Síle Lane, head of international campaigns and policy at Sense About Science. Undisclosed clinical trial results are unfortunately common - how does this impact progression in research and treatment? When results from clinical trials aren’t published it means the same research can get repeated unnecessarily. This ...

A scientist’s opinion Interview with Vesa Ruuskanen about microbial protein

A scientist’s opinion : Interview with Vesa Ruuskanen about microbial protein

Microbial protein, a scientist’s opinion Interview with Vesa Ruuskanen, post-doctoral researcher at LUT REFLEX research platform. The idea of producing “food from air” was developed by NASA and the Soviets. What was exactly the discovery of Finnish scientists that made this Neo Carbon Food project possible? In our previous Neo Carbon Food energy project we ...

A scientist’s opinion Interview with Jero Ahola about microbial protein

A scientist’s opinion : Interview with Jero Ahola about microbial protein

Microbial protein, a scientist’s opinion Interview with Jero Ahola, professor at the Department of Electrical Engineering at LUT. Is this project called Neo Carbon Food a huge step in the scientific research by Finnish scientists? Our project began in 2014 when we started thinking about electrifying the whole energy system. We’ve already known that we can ...

A scientist’s opinion : Interview with Henry Ajder about Deepfakes

A scientist’s opinion : Interview with Henry Ajder about Deepfakes

The key point I would make about regulating deepfakes is that, in some cases, new laws may be needed, but much of the harm deepfakes cause is covered by existing laws, or could be covered by amending existing laws.

A scientist’s opinion : Interview with Denis Teyssou about Deepfakes

A scientist’s opinion : Interview with Denis Teyssou about Deepfakes

Synthetic audio means that it will be possible to make any person say anything, making it even easier to make politicians or celebrities victims of deepfake as there is a lot of publicly accessible audio of their voices.

A scientist’s opinion : Interview with Sam Gregory about Deepfakes

A scientist’s opinion : Interview with Sam Gregory about Deepfakes

Rhetoric about the ‘end of truth’ plays into the hands of people who already are saying you can’t believe anything – and that is neither true of most audiovisual material, nor true yet for deepfakes. We should not panic but prepare instead.

A scientist’s opinion Interview with Renate Heinisch about new technologies in medicine

A scientist’s opinion : Interview with Renate Heinisch about new technologies in medicine

New technologies in medicine, a scientist’s opinion Interview with Renate Heinisch, pharmacist, former vice-chair of Science and Technology Options Assessment (STOA) panel and now member of the European Economic and Social Committee New technologies are going to deeply affect healthcare. Will citizens be ready? We must consider that scientific and technological innovations accompanied all of ...

A scientist’s opinion : Interview with Professor Michel Goldman about new technologies in medicine

New technologies in medicine, a scientist’s opinion Interview with Michel Goldman, founder of the Institute for Interdisciplinary Innovation in Healthcare (I3H) and former Executive Director of the Innovative Medicines Initiative (IMI). How was the idea of I3H born? At the Innovative Medicines Initiative (IMI) the main goal was to bring together pharmaceutical industry and universities, ...